Tiny Particles Could Make Hydrogen Cancer Treatment More Effective
- Authors
- Ying Wu, Meng Yuan, Jibin Song, Xiaoyuan Chen, Huanghao Yang
- Journal
- ACS Nano
- Year
- 2019
- DOI
- 10.1021/acsnano.9b05124
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
TL;DR
Scientists found that hydrogen gas can help treat inflammation and cancer, but the tricky part is getting it to the right place in your body—so they're using super tiny particles called nanomaterials to deliver it directly to sick cells, kind of like a targeted delivery system that makes the treatment way more effective.
Key Finding
Nanoparticle-based delivery systems could improve how hydrogen gas reaches target tissues compared to current systemic administration methods, potentially enhancing therapeutic effects against inflammation and cancer.
Summary
This article reviews how hydrogen gas (H2) might be used to treat inflammation and cancer. The authors explain that while hydrogen gas is safe and shows promise, current methods of delivering it throughout the body are inefficient. They propose using tiny particles called nanomaterials as delivery vehicles to target hydrogen gas directly to diseased areas, which could make treatments more effective. The article summarizes what is known about how hydrogen works and discusses future research directions, but does not present new experimental results.
Practical Takeaway
This is a review article, not a clinical study, so it does not provide evidence about hydrogen water's effects in humans. It describes early-stage research combining hydrogen gas with nanotechnology—a field still in development. Anyone interested in hydrogen therapy should await human clinical trials before drawing conclusions about real-world benefits.
Abstract
Hydrogen (H2) therapy is a highly promising strategy against several diseases due to its inherent biosafety. However, the current H2 treatment modalities rely predominantly on the systemic administration of the gas, resulting in poor targeting and utilization. Furthermore, although H2 has significant anti-tumor effects, the underlying mechanisms have not yet been elucidated. Due to their ultrasmall size, nanomaterials are highly suitable drug-delivery systems with a myriad of biomedical applications. Nanocarrier-mediated H2 delivery, as well as in situ production of H2 by nanogenerators, can significantly improve targeted accumulation of the gas and accelerate the therapeutic effects. In addition, nanomaterials can be further modified to enhance passive or active accumulation at the target site. In this Perspective, we summarize the mechanism of H2 therapy and describe possibilities for combining H2 therapy with nanomaterials. We also discuss the current challenges of H2 therapy and provide some insights into this burgeoning field.